Shell Asset Management CO Exact Sciences Corp Transaction History

Shell Asset Management CO

$2.9 Billion
Q2 2025

A detailed history of Shell Asset Management CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Shell Asset Management CO holds 1,972 shares of EXAS stock, worth $132,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,972

Previous 1,532 28.72%

Holding current value

$132,084

Previous $66,000 59.09%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	BUY	$40.31 - $58.08 $17,736 - $25,555	440 Added 28.72%	1,972 $105,000
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $83,560 - $109,548	-1,485 Reduced 49.22%	1,532 $106,000
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $37,798 - $48,460	-640 Reduced 17.5%	3,017 $223,000
Q3 2023 Nov 08, 2023	BUY	$65.94 - $99.04 $9,627 - $14,459	146 Added 4.16%	3,657 $249,000
Q2 2023 Jul 28, 2023	BUY	$62.68 - $95.05 $41,180 - $62,447	657 Added 23.02%	3,511 $330,000
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $5,049 - $7,572	-107 Reduced 3.61%	2,854 $194,000
Q4 2022 Feb 07, 2023	SELL	$30.35 - $53.15 $65,222 - $114,219	-2,149 Reduced 42.05%	2,961 $147,000
Q2 2022 Aug 09, 2022	BUY	$35.61 - $76.23 $890 - $1,905	25 Added 0.49%	5,110 $201,000
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $33,787 - $48,450	587 Added 13.05%	5,085 $356,000
Q4 2021 Feb 09, 2022	BUY	$72.5 - $100.68 $103,675 - $143,972	1,430 Added 46.61%	4,498 $350,000
Q3 2021 Nov 04, 2021	SELL	$90.24 - $124.05 $37,449 - $51,480	-415 Reduced 11.92%	3,068 $293,000
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $112,860 - $167,820	-1,205 Reduced 25.7%	3,483 $433,000
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $13,871 - $18,446	119 Added 2.6%	4,688 $618,000
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $57,773 - $82,429	580 Added 14.54%	4,569 $605,000
Q2 2020 Aug 10, 2020	SELL	$55.75 - $92.75 $42,537 - $70,768	-763 Reduced 16.06%	3,989 $347,000
Q1 2020 May 11, 2020	SELL	$37.9 - $104.44 $215,196 - $593,010	-5,678 Reduced 54.44%	4,752 $276,000
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $1.49 Million - $1.92 Million	-19,232 Reduced 64.84%	10,430 $965,000
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $2,078 - $2,817	23 Added 0.08%	29,662 $2.68 Million
Q2 2019 Aug 12, 2019	BUY	$89.51 - $118.04 $655,123 - $863,934	7,319 Added 32.79%	29,639 $3.5 Million
Q1 2019 May 09, 2019	BUY	$61.98 - $96.5 $380,681 - $592,703	6,142 Added 37.97%	22,320 $1.93 Million
Q4 2018 Feb 13, 2019	SELL	$56.04 - $82.66 $227,690 - $335,847	-4,063 Reduced 20.07%	16,178 $1.02 Million
Q2 2018 Aug 10, 2018	BUY	$37.84 - $69.96 $195,481 - $361,413	5,166 Added 34.27%	20,241 $1.21 Million
Q3 2017 Oct 20, 2017	BUY	$37.05 - $47.12 $558,528 - $710,334	15,075	15,075 $710,000

Others Institutions Holding EXAS

# of Institutions

660

Shares Held

158M

Call Options Held

1.43M

Put Options Held

2.35M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Exact Sciences Corp Transaction History